Why Aytu Biopharma Shares Are Trading Higher By 43%; Here Are 20 Stocks Moving Premarket
Aytu Biopharma surged 42.9% after strong revenue and a proposed Rosemont acquisition; Cloudastructure led gainers, while Bridger Aerospace and Stem fell.
Last updated: 2026-11-17 19:30:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Cyabra, Inc. (CYAB) operates in the SERVICES-PREPACKAGED SOFTWARE sector and is listed on NASDAQ. The stock is currently priced at $0.10, with a market capitalization of $1.57M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.08 to $6.20. This page covers its latest market performance, valuation, price trends and company information.
$1.57M | |
$0.10 | |
$0.13 | |
$0.09 | |
$0.14 | |
22.95M | |
21.47M | |
-- | |
$6.20 | |
$0.08 | |
-- | |
-- |
Cyabra, Inc. (CYAB) is currently trading at $0.10 as of 2026-11-17 19:29:00, down 27.12% ($0.04) from the previous close of $0.14
During today's regular trading session, CYAB has traded between $0.09 and $0.13, with a trading volume of 22.95M shares. The current price is near the lower end of today's range.
CYAB is down 0.98% during regular trading hours.
Over the past seven days, Cyabra, Inc. (CYAB) moved from $0.09 to $0.10, representing a gain of 14.38% ($0.01).
The stock traded between $0.08 and $0.27 during the period. The latest price is near the lower end of the 7-day range, indicating strong upward.
The average daily volume was 124.99 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.4%
CYAB is currently trading at $0.10, placing it 0.4% of the way from its 52-week low of $0.08 to its 52-week high of $6.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.
| Industry | SERVICES-PREPACKAGED SOFTWARE |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Cyabra, Inc. and CYAB stock.
Aytu Biopharma surged 42.9% after strong revenue and a proposed Rosemont acquisition; Cloudastructure led gainers, while Bridger Aerospace and Stem fell.
Gainers Cyabra (NASDAQ:CYAB) shares moved upwards by 46.3% to $0.13 during Monday's regular session. The company's market cap stands at $1.5 million. ClearOne (NASDAQ:CLRO) shares rose 32.34% to $4.46. The
U.S. stocks fell, led by a 1.1% Nasdaq drop; tech slid while staples rose. Tyson beat estimates, and small-cap movers saw sharp gains and losses.
Eligible investors can buy real shares of Cyabra, Inc. (CYAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CYAB, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CYAB shares and USD.
CYAB Shares to USD
1.00 CYAB shares = 0.101 USD
Calculations are estimates based on the latest available price and are for reference only.